Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
98M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
5.11M
-
Shares change
-
+3.33M
-
Total reported value, excl. options
-
$14.3M
-
Value change
-
+$9.33M
-
Number of buys
-
17
-
Number of sells
-
-1
-
Price
-
$2.80
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q1 2020
22 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q1 2020.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.11M shares
of 98M outstanding shares and own 5.22% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1.62M shares), FMR LLC (1.4M shares), Alyeska Investment Group, L.P. (738K shares), VIKING GLOBAL INVESTORS LP (587K shares), VANGUARD GROUP INC (222K shares), RENAISSANCE TECHNOLOGIES LLC (209K shares), TWO SIGMA INVESTMENTS, LP (64.3K shares), UBS Group AG (38K shares), Ensign Peak Advisors, Inc (37.9K shares), and TWO SIGMA ADVISERS, LP (36.4K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.